Literature DB >> 22847735

A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.

J M McGree1, C C Drovandi, A N Pettitt.   

Abstract

Here we present a sequential Monte Carlo approach that can be used to find optimal designs. Our focus is on the design of population pharmacokinetic studies where the derivation of sampling windows is required, along with the optimal sampling schedule. The search is conducted via a particle filter which traverses a sequence of target distributions artificially constructed via an annealed utility. The algorithm derives a catalog of highly efficient designs which, not only contain the optimal, but can also be used to derive sampling windows. We demonstrate our approach by designing a hypothetical population pharmacokinetic study, and compare our results with those obtained via a simulation method from the literature.

Mesh:

Substances:

Year:  2012        PMID: 22847735     DOI: 10.1007/s10928-012-9265-1

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  9 in total

1.  Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.

Authors:  Sylvie Retout; France Mentré
Journal:  J Biopharm Stat       Date:  2003-05       Impact factor: 1.051

2.  A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.

Authors:  Lee Kien Foo; James McGree; Stephen Duffull
Journal:  Pharm Stat       Date:  2012-03-12       Impact factor: 1.894

3.  Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerations.

Authors:  J M McGree; J A Eccleston; S B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-02-18       Impact factor: 2.745

4.  Adaptive design optimization: a mutual information-based approach to model discrimination in cognitive science.

Authors:  Daniel R Cavagnaro; Jay I Myung; Mark A Pitt; Janne V Kujala
Journal:  Neural Comput       Date:  2010-04       Impact factor: 2.026

5.  Optimisation of sampling windows design for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-09       Impact factor: 2.745

6.  Prospective evaluation of a D-optimal designed population pharmacokinetic study.

Authors:  Bruce Green; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-04       Impact factor: 2.745

7.  An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Biopharm Stat       Date:  2009       Impact factor: 1.051

8.  Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.

Authors:  Gordon Graham; Leon Aarons
Journal:  Stat Med       Date:  2006-12-15       Impact factor: 2.373

9.  Evaluation of uncertainty parameters estimated by different population PK software and methods.

Authors:  Céline Dartois; Annabelle Lemenuel-Diot; Christian Laveille; Brigitte Tranchand; Michel Tod; Pascal Girard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-01-10       Impact factor: 2.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.